CompoAtlas

NeuroPro

Natural health product licensed in Canada

Licence holder
Neurodyn Inc.
NPN or DIN-HM
80076020
Status
Active licence
Licence date
8 March 2017
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Panax ginseng C.A. Meyer (Araliaceae)

Source : Panax ginseng - racine

Extract : Matériel brut sec

Extraction ratio : 17.857:1

Dry plant equivalent : 1 Grammes

Potency : 0.01 Grammes Total ginsenosides

0.056 GrammesNot calculated
Panax ginseng C.A. Meyer (Araliaceae)

Source : Panax ginseng - racine

Not specifiedNot calculated

Non-medicinal ingredients

Maltodextrine, Lécithine, Dioxyde de silicium, Cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsuleminimum: 1 day ; maximum: 2 days

Uses authorised in Canada

(Used in Herbal Medicine to) help(s) support cognitive function and/or reduce mental fatigue (in cases of mental stress). Used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80076020

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line